GlassScriptPhysician profile
Joel Vansickler
NPI 1245281864
$632.71
in general payments reported to CMS, 2019-2025
16 companies · $73.84 in 2025
The $73.84 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $53.10 · 2021: $54.68 · 2022: $79.84 · 2023: $215 · 2025: $73.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $104.63 | 2023 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Biocomposites INC | $73.84 | 2025 | Stimulan |
| Mallinckrodt Hospital Products INC. | $61.19 | 2021-2022 | |
| Mozarc Medical US LLC | $53.23 | 2023 | Palindrome |
| Aurinia Pharma U.S., INC. | $49.70 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $45.34 | 2019-2023 | Jynarque |
| Opko Pharmaceuticals, LLC | $43.29 | 2021-2023 | Rayaldee |
| Vifor Pharma, INC. | $41.34 | 2020 | |
| Baxter Healthcare | $34.43 | 2019 | |
| Mallinckrodt Enterprises LLC | $29.09 | 2019 | |
| Abbott Laboratories | $24.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.58 | 2019 | |
| Horizon Therapeutics Plc | $13.96 | 2023 | Krystexxa |
| Fresenius USA Marketing, INC. | $12.46 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Vansickler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.